Optinose Reports First Quarter 2021 Financial Results and Operational Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
OptiNose (OPTN) Tops Q1 EPS by 4c, Revenues Beat
May 5, 2021 7:14 AM EDTOptiNose (NASDAQ: OPTN) reported Q1 EPS of ($0.49), $0.04 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $11.96 million versus the consensus estimate of $11.1 million.
XHANCE net revenues increased 55% in the first quarter of 2021 compared to first quarter 2020, stated CEO Peter Miller. We believe this is strong growth, particularly in the context of the continuing impact of the COVID-19 pandemic on the number of patients visiting physician offices and pandemic-related restrictions that continue to limit in-person detailing of physician offices by our territory managers. Improvement to the business environment is just... More
